[1] |
Boyle GM. Therapy for metastatic melanoma: an overview and update[J]. Expert Rev Anticancer Ther, 2011, 11(5): 725⁃737. DOI: 10.1586/era.11.25.
|
[2] |
Davey RJ, van der Westhuizen A, Bowden NA. Metastatic melanoma treatment: combining old and new therapies[J]. Crit Rev Oncol Hematol, 2016, 98: 242⁃253. DOI: 10.1016/j.critrevonc. 2015.11.011.
|
[3] |
Kalluri R, Weinberg RA. The basics of epithelial⁃mesenchymal transition[J]. J Clin Invest, 2009, 119(6): 1420⁃1428. DOI: 10. 1172/JCI39104.
|
[4] |
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial⁃mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178⁃196. DOI: 10.1038/nrm3758.
|
[5] |
Lin CY, Tsai PH, Kandaswami CC, et al. Matrix metalloproteinase⁃9 cooperates with transcription factor Snail to induce epithelial⁃mesenchymal transition[J]. Cancer Sci, 2011, 102(4): 815⁃827. DOI: 10.1111/j.1349⁃7006.2011.01861.x.
|
[6] |
Orlichenko LS, Radisky DC. Matrix metalloproteinases stimulate epithelial⁃mesenchymal transition during tumor development[J]. Clin Exp Metastasis, 2008, 25(6): 593⁃600. DOI: 10.1007/s10585⁃008⁃9143⁃9.
|
[7] |
Massagué J. TGFbeta in Cancer[J]. Cell, 2008, 134(2): 215⁃230. DOI: 10.1016/j.cell.2008.07.001.
|
[8] |
Javelaud D, Mohammad KS, McKenna CR, et al. Stable over of Smad7 in human melanoma cells impairs bone metastasis[J]. Cancer Res, 2007, 67(5): 2317⁃2324. DOI: 10.1158/0008⁃5472.CAN⁃06⁃3950.
|
[9] |
Javelaud D, Delmas V, Möller M, et al. Stable over of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo[J]. Oncogene, 2005, 24(51): 7624⁃7629. DOI: 10.1038/sj.onc.1208900.
|
[10] |
Ben SI, Le MY, Tanti JF, et al. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?[J]. Mol Cancer Ther, 2010, 9(5): 1092⁃1099. DOI: 10.1158/1535⁃7163.MCT⁃09⁃1186.
|
[11] |
Cerezo M, Tichet M, Abbe P, et al. Metformin blocks melanoma invasion and metastasis development in AMPK/p53⁃dependent manner[J]. Mol Cancer Ther, 2013, 12(8): 1605⁃1615. DOI: 10.1158/1535⁃7163.MCT⁃12⁃1226⁃T.
|
[12] |
Zhang J, Shen C, Wang L, et al. Metformin inhibits epithelial⁃mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4[J]. Biochem Biophys Res Commun, 2014, 452(3): 746⁃752. DOI: 10.1016/j.bbrc.2014.08.154.
|
[13] |
Cufí S, Vazquez⁃Martin A, Oliveras⁃Ferraros C, et al. Metformin against TGFβ⁃induced epithelial⁃to⁃mesenchymal transition (EMT): from cancer stem cells to aging⁃associated fibrosis[J]. Cell Cycle, 2010, 9(22): 4461⁃4468. DOI: 10.4161/cc.9.22. 14048.
|
[14] |
Lin H, Li N, He H, et al. AMPK inhibits the stimulatory effects of TGF⁃β on Smad2/3 Activity, cell migration, and epithelial⁃to⁃mesenchymal transition[J]. Mol Pharmacol, 2015, 88(6): 1062⁃1071. DOI: 10.1124/mol.115.099549.
|